KAPLAN GILLA (CIK 1247024) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-31). Recent activity: Buy AVTX (3,166 shares), Buy TYRA (14,295 shares), Sell TYRA (14,295 shares), Sell TYRA (53,172 shares), Sell TYRA (53,172 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 3,166 | $0 |
| 2026-03-27 | Tyra Biosciences, Inc. (TYRA) | Director | Buy | 14,295 | $32,164 |
| 2026-03-27 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 14,295 | $528,486 |
| 2026-03-27 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 53,172 | $119,637 |
| 2026-03-27 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 53,172 | $2.0M |
| 2025-06-20 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 10 | $104 |
| 2025-06-20 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 9,568 | $93,575 |
| 2025-06-16 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 30,000 | $309,300 |
| 2025-06-16 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 15,000 | $154,650 |
| 2025-06-16 | Tyra Biosciences, Inc. (TYRA) | Director | Sell | 6,814 | $70,729 |
| 2025-04-01 | Avalo Therapeutics, Inc. (AVTX) | Director | Buy | 3,167 | $0 |
Source: SEC Form 4 filings · as of 2026-03-31